We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » FDAnews Books Library » Files

FDAnews Books Library

 

Gain Access to All Books and Reports

Our Books Library gives you year-round unrestricted access to all our books and reports.

They can be accessed, searched, downloaded and read anywhere, anytime. Topics covered include inspections, auditing, validation, recalls, pharmacovigilance, biosimilars, adverse events, QSR Data, supply chain, financial disclosure requirements and much more. You’ll automatically receive every new book we publish — we'll send you notifications to alert you of each new book in the library.

LOGIN

BUY NOW Single-User 1-Year Unlimited Access $997

Also available: Take advantage of our multi-user and site licenses of the FDAnews Books Library so you’ll have the most-informed workforce! Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote.

Search by keyword (title of book maybe) or simply scroll through the list of titles to find what you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

FDA’s Alternative Inspection Tools: Expert Answers to Drug and Biologics Manufacturers’ Questions

May 11, 2022
This report, in a question-and-answer format, covers the implications of the shift in the FDA’s inspection model from onsite to remote approaches.

GCP Questions, FDA Answers, 2022 Edition

April 6, 2022
The latest volume in this best-selling series provides answers from the FDA’s Good Clinical Practice Program to a variety of questions related to handling adverse events, investigational product, documentation and storage, investigator responsibilities and more.

Proving Comparability in Cell and Gene Therapy Development: Untangling FDA Requirements

April 6, 2022
Gain a thorough understanding of the FDA’s comparability requirements and how to meet them.

Supply-Chain Solutions: Managing Demand and Logistics in a Postpandemic World

April 6, 2022
Learn about measures drugmakers and suppliers working together can take to ease shortages and keep the industry moving forward during the pandemic and beyond.

Safety Reporting Overload in Clinical Trials: FDA and Site Perspectives on Overreporting of Adverse Events

March 9, 2022
The FDA and trial sites both are struggling under the weight of too many safety reports and both parties are tired of the hassle. This report explains the FDA’s opinion of where the problems lie and outlines what sites can do to reduce the burden.

Best Practices for Clinical Trial Site Management, Vol. 2

March 9, 2022
This report gives readers hands-on guidance for performing a variety of job responsibilities and provides the latest thinking on best practices in those areas.

Measuring Success in Decentralized Trials: Metrics that Drive Improvement

February 9, 2022
This report discusses the challenges and opportunities of using unique metrics to measure the success of decentralized trials (DCT). Using a risk management approach, a metrics analysis plan can be created for DCTs that focuses on potential problem areas and identifies what data are needed to track them.

FDA’s Safety Reporting Requirements: Developing a Compliant Pharmacovigilance Plan

February 9, 2022
Compliance begins with clarification: this report makes clear the requirements for reporting adverse events and other safety issues, it identifies the sources of reportable safety information and the forms/online portals used for FDA reporting, and it simplifies records retention requirements and the agency’s periodic adverse drug event inspections program.

FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

February 9, 2022
This report answers the key questions that will enable you to prepare for harmonization: Where does ISO 13485 differ from the QSR and how does the FDA intend to close those gaps? When will this happen? How can you get involved in this effort and make sure your interests are represented?

The MDSAP in 2022: Policies, Procedures and Developments

January 5, 2022
The MDSAP in 2022 provides a comprehensive view of the current state of the MDSAP: its principles and procedures, nations that have joined the program’s original five members and those currently considering joining, policy developments in individual countries, guidance from the FDA and more.

Designing Secure Medical Devices: Building Cybersecurity into the Development Process

January 5, 2022
Designing Secure Medical Devices explains how to incorporate risk and vulnerability assessment into each stage of development, from initial design to validation, testing and implementation, so you stay compliant with FDA’s requirements on cybersecurity.

Selecting and Implementing Electronic Document Management Systems in the EU

December 9, 2021
The drug and device industries are rapidly making the transition from paper record-keeping systems to electronic data management to increase efficiency. But new electronic systems come with many costs, and manufacturers that work in the EU need to know how to select and/or develop systems that best meet their needs. You’ll find all the answers you need in this guide.
Previous 1 2 3 4 5 6 7 8 9 … 19 20 Next

Upcoming Events

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

  • 07Mar

    FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Updates Smiths Medical CADD System Recall to Class I

  • Eisai’s New Alzheimer’s Drug Leqembi Hits the U.S. Market

  • Boston Scientific’s Single Use Ureteroscope Gets FDA Clearance

  • Gilead’s Trodelvy Gets Expanded Approval in Breast Cancer

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing